S. Karlsson et al. / Tetrahedron: Asymmetry 10 (1999) 2605–2616
2615
(m, 2H); 5.16–5.19 (m, 1H); 5.89 (d, 1H, J=6.9 Hz); 7.17–7.62 (m, 13H); 7.61 (d, 1H, J=7.6 Hz). 13
C
NMR (125 MHz, CDCl3) δ 37.9, 45.3, 51.1, 58.3, 59.7, 62.1, 63.2, 78.2, 125.2, 126.6, 126.8, 126.9, 127.8
(2Cs), 128.2 (2Cs), 128.3, 128.5 (4Cs), 129.8, 138.8, 139.2, 139.4, 143.1, 152.6, 173.9. M.p. 63–66°C.
Anal. calcd for C28H26N2O3·0.1H2O: C, 76.4; H, 6.0; N, 6.4. Found: C, 76.2; H, 6.0; N, 6.4.
(3R,4S)-5e: [α]D25=−67.0 (c=1.0, CH2Cl2). H NMR (500 MHz, CDCl3) δ 2.71 (t, 1H, J=8.5 Hz);
1
2.87 (dd, 1H, J=5.7, 9.6 Hz); 3.19–3.23 (m, 2H); 3.28–3.38 (m, 2H); 3.66 (d, 1H, J=13.0 Hz); 3.75 (d,
1H, J=13.0 Hz); 4.09 (q, 1H, J=7.6 Hz); 4.21–4.25 (m, 1H); 5.21–5.24 (m, 1H); 5.93 (d, 1H, J=7.0 Hz);
7.12–7.38 (m, 13H); 7.56 (d, 1H, J=7.7 Hz). 13C NMR (125 MHz, CDCl3) δ 38.0, 45.8, 50.7, 58.0, 59.9,
61.5, 63.4, 77.8, 125.1, 126.5, 127.0, 127.2, 127.6 (2Cs), 128.1, 128.3 (2Cs), 128.4 (2Cs), 128.7 (2Cs),
129.8, 138.8, 139.0, 139.4, 142.8, 152.5, 174.2. M.p. 114–116°C. Anal. calcd for C28H26N2O3·0.1H2O:
C, 76.4; H, 6.0; N, 6.4. Found: C, 76.2; H, 6.0; N, 6.4.
4.15. (−)-(3S,4R)- and (−)-(3R,4S)-1-Benzyl-4-phenyl-3-[(10 S,50R)-camphorsultam-30-yl)-carbonyl]-
pyrrolidine 4f and 5f
Compounds 4f and 5f were prepared and isolated, according to the general method for the 1,3-dipolar
cycloaddition (method A), from 1f (278 mg, 0.8 mmol) and 2 (0.38 g, 1.6 mmol). The mixture of 4f and
5f was separated by column chromatography [SiO2, ethyl acetate (15%) in n-hexane as eluent] to give 4f
(230 mg, 0.49 mmol) and 5f (78 mg, 0.16 mmol) as colourless solids in >99% purity (GC).
(3S,4R)-4f: [α]D25=−119.8 (c=0.5, CH2Cl2); H NMR (500 MHz, CDCl3) δ 0.94 (s, 3H); 1.04 (s,
1
3H); 1.26–1.38 (m, 2H); 1.85–1.89 (m, 3H); 2.06–2.07 (m, 2H); 2.67 (t, 1H, J=8.4 Hz); 2.82 (dd,
1H, J=5.9, 9.6 Hz); 3.14 (t, 1H, J=8.4 Hz); 3.23 (t, 1H, J=9.5 Hz); 3.36 (d, 1H, J=13.7 Hz); 3.42 (d,
1H, J=13.7 Hz); 3.61 (d, 1H, J=13.1 Hz); 3.73–3.77 (m, 2H); 3.86 (t, 1H, J=6.3 Hz); 4.04 (q, 1H,
J=7.3 Hz); 7.15–7.34 (m, 10H). 13C NMR (125 MHz, CDCl3) δ 19.8, 20.8, 26.4, 32.8, 38.4, 44.6, 45.1,
47.7, 48.3, 51.9, 53.0, 59.2, 59.7, 61.5, 65.3, 126.4, 126.9, 127.6 (2Cs), 128.2 (2Cs), 128.4 (2Cs), 128.6
(2Cs), 138.9, 142.8, 172.7. M.p. for C28H34N2O3S·HCl·0.5H2O: 123–129°C. HCl-salt: Anal. calcd for
C28H34N2O3S·HCl·0.5H2O: C, 64.2; H, 6.9; N, 5.3. Found: C, 64.6; H, 6.8; N, 5.4.
(3R,4S)-5f: [α]D25=−2.0 (c=0.5, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 0.83 (s, 3H); 0.88 (s, 3H);
1.26–1.33 (m, 2H); 1.77–1.92 (m, 4H); 2.02 (dd, 1H, J=7.8, 13.8 Hz); 2.81 (dd, 1H, J=7.8, 9.2 Hz);
2.97 (dd, 1H, J=7.3, 9.5 Hz); 3.12 (dd, 1H, J=7.8, 9.2 Hz); 3.18 (t, 1H, J=8.9 Hz); 3.33 (d, 1H, J=13.8
Hz); 3.38 (d, 1H, J=13.8 Hz); 3.67 (d, 1H, J=13.1 Hz); 3.74 (q, 1H, J=7.8 Hz); 3.78–3.82 (m, 3H);
7.15–7.37 (m, 10H). 13C NMR (125 MHz, CDCl3) δ 19.8, 20.5, 26.4); 32.8, 38.5, 44.7, 47.6, 48.1,
50.3, 51.5, 53.1, 57.8, 60.1, 61.2, 65.2, 126.7, 126.9, 127.5 (2Cs), 128.2 (2Cs), 128.4 (2Cs), 128.6
(2Cs), 139.1, 141.6, 173.8. M.p. for C28H34N2O3S·HCl·1.5H2O: 124–127°C. HCl-salt: Anal. calcd for
C28H34N2O3S·HCl·1.5H2O: C, 62.0; H, 7.1; N, 5.2. Found: C, 62.4; H, 6.9; N, 5.4.
4.16. (−)-(3S,4R)- and (+)-(3R,4S)-1-Benzyl-4-phenyl-3-[(10 ,20,50,60-di-O-isopropyliden-D-
glycofuranosyl)-carbonyl]-pyrrolidine 4g and 5g
Compounds 4g and 5g were prepared and isolated, according to the general method for the 1,3-dipolar
cycloaddition (method A), from 1g (300 mg, 0.77 mmol) and 2 (365 mg, 1.54 mmol) with the exception
for the work-up procedure where the organic phase was washed only with NaHCO3. The mixture of 4g
and 5g was separated by several flash column chromatographies [SiO2, diethylether (10%) in CH2Cl2 as
eluent]. Pure fractions were collected to give 4g and 5g as colourless oils in a total yield of 95%.
(3S,4R)-4g: [α]D25=−32.8 (c=0.5, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 1.25 (s, 3H); 1.29 (s, 3H);
1.38 (s, 3H); 1.50 (s, 3H); 2.72 (dd, 1H, J=6.5, 9.3 Hz); 2.93 (dd, 1H, J=6.5, 9.4 Hz); 2.99 (t, 1H, J=8.8